Detalles de la búsqueda
1.
Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study).
Diabetes Obes Metab
; 26(3): 961-970, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38073422
2.
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 1 study).
Diabetes Obes Metab
; 25(6): 1503-1511, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36722623
3.
Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?
Endocr J
; 69(5): 495-509, 2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819409
4.
Effect of nanoparticle-rich diesel exhaust on testicular and hippocampus steroidogenesis in male rats.
Inhal Toxicol
; 24(8): 459-67, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22712718
5.
The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67).
J Diabetes Investig
; 13(11): 1834-1841, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35735780
6.
Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study).
BMJ Open
; 12(5): e056885, 2022 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35584872
7.
The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetes.
Geriatr Gerontol Int
; 22(8): 560-567, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35773969
8.
Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study).
BMJ Open Diabetes Res Care
; 10(6)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36379585
9.
Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study.
Diabetes Res Clin Pract
; 192: 110091, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36174777
10.
Association between 25 Hydroxyvitamin D Concentrations and Lipid Profiles in Japanese with Type 2 Diabetes Mellitus.
J Nutr Sci Vitaminol (Tokyo)
; 67(5): 266-272, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34719611
11.
Efficacy and Safety of Low-Dose Pemafibrate Therapy for Hypertriglyceridemia in Patients with Type 2 Diabetes.
JMA J
; 4(2): 135-140, 2021 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33997447
12.
Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin.
J Diabetes Investig
; 12(8): 1395-1399, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33325645
13.
Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study).
Diabetes Ther
; 12(3): 955-964, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33491111
14.
Favorable effect of sodium-glucose cotransporter 2 inhibitor, dapagliflozin, on non-alcoholic fatty liver disease compared with pioglitazone.
J Diabetes Investig
; 12(7): 1272-1277, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131199
15.
Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.
J Diabetes Investig
; 12(8): 1417-1424, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33421309
16.
Quercetin attenuates oxidative damage induced by treatment of embryonic chicken spermatogonial cells with 4-nitro-3-phenylphenol in diesel exhaust particles.
Biosci Biotechnol Biochem
; 74(5): 934-8, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20460716
17.
Effects of in utero exposure to nanoparticle-rich diesel exhaust on testicular function in immature male rats.
Toxicol Lett
; 185(1): 1-8, 2009 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19100318
18.
Endocrine disruptive effect of 3-methyl-4-nitrophenol isolated from diesel exhaust particles in Hershberger assay using castrated immature rats.
Biosci Biotechnol Biochem
; 73(9): 2018-21, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19734673
19.
Effects of inhaled nanoparticle-rich diesel exhaust on regulation of testicular function in adult male rats.
Inhal Toxicol
; 21(10): 803-11, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19653803
20.
Improvement of an efficient separation method for chemicals in diesel exhaust particles: analysis for nitrophenols.
Environ Sci Pollut Res Int
; 15(4): 318-21, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18437438